Rula Al-Aouar, MD
Gynecology · Dearborn Heights, MINPI 1700907144
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,439 of the $1,750 with a category attached, or 82.2%. 27 manufacturers reported payments, led by Myovant Sciences Inc. at 42.3% of the total. Reporting peaked in 2021 at $650 and has fallen 94.1% since, to $38 in 2025.
Across 83 payments — averaging $21.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Myovant Sciences Inc.$741
- AbbVie$211
- Aspira Women's Health Inc$164
- Coopersurgical, Inc.$61
- Exeltis, USA Inc.$57
- Takeda Pharmaceuticals U.S.A., Inc.$50
- plus $468 from 21 others
What the payments were for
- Food & beverage$1,43982%
- Education$31118%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Myovant Sciences Inc. | 29 | $741 |
| AbbVie(2 entities) | 10 | $211 |
| Aspira Women's Health Inc | 3 | $164 |
| Coopersurgical, Inc. | 4 | $61 |
| Exeltis, USA Inc. | 4 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $50 |
| Lupin Inc. | 4 | $49 |
| AMAG Pharmaceuticals, Inc. | 3 | $42 |
| Hologic Sales And Service, LLC | 2 | $42 |
| Lilly USA, LLC | 2 | $30 |
| Organon | 1 | $27 |
| Mylan Pharmaceuticals Inc. | 2 | $26 |
| Amgen | 2 | $25 |
| Astellas Pharma US Inc | 1 | $23 |
| Covidien LP | 1 | $23 |
| Baxter Healthcare | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Gilead | 1 | $19 |
| Merck | 1 | $16 |
| AstraZeneca | 1 | $16 |
| Shield Therapeutics Inc | 1 | $15 |
| Bayer | 1 | $15 |
| Minerva Surgical, Inc | 1 | $15 |
| Alfasigma USA, Inc. | 1 | $12 |
| Duchesnay USA Incorporated | 1 | $12 |
| Novo Nordisk | 1 | $12 |
| Pfizer | 1 | $11 |
How this compares
$1,750 in reported general payments places this provider in the 70th percentile of 50 gynecology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Triamcinolone Acetonide | 12 | $34 |
| Fluconazole | 16 | $24 |
Paid to pharmacies, not to this prescriber.
Other gynecology in Dearborn Heights
- Mona FakihDearborn Heights$11K
- Jay BermanSouthfield$218K
- John LagrandGrand Rapids$58K
- Noor Dasouki AbualnadiAnn Arbor$47K
- Deborah RussellSaginaw$30K
- Roderick CairgleDetroit$8K
- Lisa CardwellSouthfield$7K
- Michele ThomasSouthfield$6K
- Joseph RakowskiGrosse Pointe$6K
- Ginger ConnorLake Orion$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.